TSNARE1 rs12675715: Sleep Traits and Neurodevelopment
The genetic variant rs12675715 is a common single nucleotide polymorphism located in an intronic region of the TSNARE1 gene on chromosome 8. Large-scale genome-wide association studies have identified this variant through statistical associations with sleep medication purchases and persistent insomnia symptoms. It highlights emerging biological connections between cortical intracellular trafficking pathways and complex neurodevelopmental sleep phenotypes.
What each genotype means
Typical sleep medication association
You carry two copies of the major A allele for rs12675715 in TSNARE1. Large-scale population studies show this common genotype is not linked to increased likelihood of sleep medication purchases or insomnia symptoms. This reflects average baseline genetic risk within the examined European cohorts, but sleep quality is influenced by many broader lifestyle and health factors.
Carried by approximately 52% of individuals of European ancestry.
Slightly elevated insomnia trait association
You have one copy of the G allele associated with sleep medication purchases and persistent insomnia traits in genome-wide association studies. Because the overall evidence remains limited and reflects minor statistical shifts across populations, carrying this allele does not diagnose insomnia or predict poor sleep. If you have concerns about persistent sleep disturbances or sleep medications, discuss your options and sleep hygiene with a qualified healthcare professional.
Carried by approximately 40% of individuals of European ancestry.
Modestly elevated insomnia trait association
You carry two copies of the minor G allele identified in neurodevelopmental pathway studies linking TSNARE1 variation to insomnia complaints and sleep medication usage. Population-level research shows a modest statistical association with these sleep-related traits, though individual sleep patterns depend far more on lifestyle, environment, and overall health. Never initiate, stop, or adjust prescription sleep medications without guidance from your doctor or pharmacist.
Carried by approximately 8% of individuals of European ancestry.
Genomic Location and Molecular Identity
The single nucleotide polymorphism rs12675715 is situated within an intron of the TSNARE1 gene, located on the short arm of human chromosome 8. Because it resides in non-coding intronic sequence rather than an exon, rs12675715 does not alter the amino acid sequence of the resulting protein directly. Instead, variants in these non-coding segments often act as regulatory flags, influencing transcription efficiency, alternative splicing patterns, or serving as proxy markers for nearby causal genomic variation in linkage disequilibrium. In dbSNP, rs12675715 is cataloged with typical single-base substitutions involving cytosine and thymine alleles. Modern genomic databases utilize these non-coding single-nucleotide markers to map broad regulatory architecture across human tissues, particularly evaluating how subtle differences in non-coding DNA can correlate with downstream physiological traits across diverse population cohorts.
Biological Role of the TSNARE1 Gene
The TSNARE1 gene encodes t-SNARE domain-containing protein 1, a member of the syntaxin-like superfamily of proteins involved in membrane fusion and intracellular trafficking. Within cortical neurons, the tSNARE1 protein functions predominantly within endosomal compartments, helping coordinate vesicle transport and protein sorting between early and late endosomes. Functional neurobiology studies have demonstrated that tSNARE1 is critical for proper neuronal development, dendritic morphology, and synaptic functioning. Historically, the TSNARE1 genomic locus drew scientific attention due to strong genome-wide links with psychiatric conditions, including schizophrenia and bipolar disorder. Because normal synaptic maintenance and vesicle turnover in cortical networks are vital for regulating sleep-wake homeostasis, genetic variation altering TSNARE1 expression can provide a functional window into how basic neuronal vesicle dynamics influence broader neurological and behavioral traits.
GWAS Associations with Sleep and Medication Patterns
Recent biobank-scale research, notably utilizing the FinnGen and UK Biobank cohorts, uncovered rs12675715 in genome-wide association studies evaluating prescription sleep medication purchases as a proxy for severe, persistent insomnia. Sleep problems frequently overlap with neuropsychiatric traits, and evaluating registry-based sleep medication records offers objective insights into clinically impactful insomnia phenotypes. In these analyses, rs12675715 within TSNARE1 emerged among loci linked to non-benzodiazepine sleep aid utilization. The biological evidence for rs12675715 is currently categorized as limited because it reflects statistical correlation rather than direct functional causation. Individual common variants typically exert very small effect sizes on polygenic behaviors, meaning rs12675715 alone explains only a minute fraction of overall sleep architecture. Rather than dictating sleep quality, it serves as a statistical signpost connecting neurodevelopmental pathways with nighttime disturbance.
Translating Research to Health and Daily Life
Finding rs12675715 in a personal genetic profile provides educational insight into polygenic traits, but it does not represent a medical diagnosis or predict individual treatment outcomes. Insomnia and sleep continuity are deeply multifactorial, heavily influenced by circadian rhythm management, sleep hygiene, stress, medical history, and hundreds of inherited genetic markers. Consequently, this variant cannot determine whether someone will develop a sleep disorder or how they might react to a sedative. For anyone considering or currently taking prescription or over-the-counter sleep aids, medication choices and dosages must always be discussed directly with a qualified physician or clinical pharmacist. Knowledge of a single TSNARE1 marker is a tool for exploring human biology and scientific discovery rather than a guide for personal medical decision-making.
How common is this variant?
The minor allele frequency for rs12675715 is approximately 0.28 in populations of European ancestry according to gnomAD, with the variant being widely observed across global populations at varying frequencies.
Frequently asked questions
Does having the rs12675715 variant mean I will suffer from insomnia?
No. The rs12675715 variant is merely a statistical marker discovered in large population-wide surveys. Having one or two copies of a specific allele confers only a very slight shift in relative association, and sleep quality is determined by environmental factors, lifestyle habits, and hundreds of other genes.
Can this genetic variant tell my doctor which sleep medication to prescribe?
No. Current clinical pharmacogenomics guidelines do not include TSNARE1 or rs12675715 for prescribing or dosing sleep aids. Any decisions regarding sleep medications, safety, or dosage must be made through personal consultations with your doctor or pharmacist based on your medical history.
Why do researchers study sleep medication purchases to understand genetics?
Self-reported sleep questionnaires can be subjective and prone to recall bias. Nationwide electronic prescription registries provide objective, high-volume records that allow genetic epidemiologists to analyze severe, chronic sleep complaints across hundreds of thousands of participants in national biobanks.
What is the function of the TSNARE1 gene in the body?
TSNARE1 encodes a syntaxin-like protein that participates in intracellular trafficking and endosomal protein sorting inside cortical neurons. Scientists study it because proper membrane fusion and vesicle transport are critical for healthy neuronal communication, synaptic plasticity, and broader brain functions.
Sources & further reading
Educational information only, last refreshed 9/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12675715?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29